Not applicableCompletedINTERVENTIONAL
The Effect of Liraglutide on Pancreatic Hormones and Its Size
ClinicalTrials.gov · NCT03520062 · Registry updated: 2020-03-24
- Condition / research focus
- Obesity
- Sponsor
- Nicolai Jacob Wewer Albrechtsen
- Countries with listed sites
- Denmark
- Registry dates and results
- Start: 2017-08-15. Completion: 2020-01-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Department of Endocrinology
Hvidovre, Denmark
Site recruitment: Not reported